Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immutep Ltd ADR (NQ: IMMP ) 2.110 -0.040 (-1.86%) Streaming Delayed Price Updated: 1:49 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Immutep Ltd ADR < Previous 1 2 3 Next > Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September September 16, 2024 Via Benzinga Topics Stocks Exposures US Equities Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session July 29, 2024 Via Benzinga Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session July 12, 2024 Via Benzinga Immutep Touts Encouraging Data From Efti Triple Combination Therapy In Lung Cancer Setting May 24, 2023 Via Benzinga Maxim Group Maintains Buy Rating for Immutep: Here's What You Need To Know May 18, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday July 12, 2024 Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday Via InvestorPlace Australia Based Cancer Focused Immutep's Lead Cancer Drug Shows 'Meaningful Response' In Untreated Head & Neck Cancer, Stock Soars July 12, 2024 Immutep announces results from Cohort B of the TACTI-003 Phase 2b trial. The combination of eftilagimod alfa and Merck's Keytruda shows a 35.5% ORR and 58.1% DCR in PD-L1 negative head and neck cancer... Via Benzinga Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket July 12, 2024 Via Benzinga Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session June 27, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday June 27, 2024 Pre-market stock movers are worth checking out on Thursday as we dig into all of the biggest news moving shares this morning! Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Intraday Session April 24, 2024 Via Benzinga Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday? April 24, 2024 Immutep releases preliminary results from TACTI-003 trial showing promising outcomes for first-line treatment of HNSCC patients without PD-L1 expression. Final data expected in H1 CY2024. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 24, 2024 Via Benzinga Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B April 24, 2024 From Immutep Limited Via GlobeNewswire Cancer Focused Immutep's Stock Soars On Tuesday - Here's Why March 05, 2024 Immutep releases promising safety and efficacy data for 90mg eftilagimod alpha combined with paclitaxel in HR+/HER2- metastatic breast cancer. No serious adverse events were reported, and a 50% overall... Via Benzinga Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023 October 24, 2023 From Immutep Limited Via GlobeNewswire Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer October 23, 2023 From Immutep Limited Via GlobeNewswire 7 Stocks That Could Triple Your Money by 2024 August 09, 2023 If you want to get well ahead of the market and don’t mind the risk factor, check out these stocks to triple your money. Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023 August 03, 2023 Via Benzinga 3 Best Penny Stocks Under $3 to Buy in June June 14, 2023 If you don’t mind the immense risks associated with high-potential opportunities, these best penny stocks under $3 could be for you. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 24, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 17, 2023 Via Benzinga Immutep Shares Spike As Cancer Tratement Shows Favorable Results In Phase 2 Trial May 17, 2023 Immutep Limited's (NASDAQ: IMMP) lead candidate — a soluble LAG-3 protein, in combination with Merck & Co Inc (NYSE: MRK) Keytruda (pembrolizumab) — Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 17, 2023 Via Benzinga Immutep’s Efti in Combination with Pembrolizumab Achieves Excellent Initial Overall Survival Benefit in 1st Line Non-Small Cell Lung Cancer May 17, 2023 From Immutep Limited Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday May 17, 2023 We're starting off Wednesday with a look at the biggest pre-market stock movers traders will want to keep an eye on this morning! Via InvestorPlace Immutep Receives Approval to Initiate INSIGHT-005 Trial Evaluating Eftilagimod Alpha and Anti-PD-L1 Therapy BAVENCIO® May 01, 2023 From Immutep Limited Via GlobeNewswire 7 Best Penny Stocks Under $3 to Buy in April April 12, 2023 If you have the audacity to consider ultra-speculative opportunities, these ideas for best penny stocks under $3 might be appealing. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 03, 2023 We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning! Via InvestorPlace Why Did Immutep Ltd Stock Soar Recently? December 28, 2022 Analysts and investors alike appear enamored with Immutep Ltd, whose earnings are growing; more of which could come from their latest product candidate. Via MarketBeat Topics Initial Public Offering Exposures Product Safety Securities Market < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.